Clinical Trial Update: Lispro Mix 25 vs. Glargine in Type 2 Diabetics [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Lispro Mix 25 to Glargine in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glargine (insulin glargine)
• Lispro Mix 25 (insulin lispro protamine suspension and insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED